MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM.
Chung L, et al.
Arthritis Rheum. 2009 Mar;60(3):870-7. doi: 10.1002/art.24351.
Arthritis Rheum. 2009.
PMID: 19248104
Free article.
Clinical Trial.